Home » Topics » Conferences

Conferences
RSS

NSAID from Sigma-Tau is devoid of GI side effects

Aug. 13, 1998

Endothelin ETA antagonist YM-598 undergoes preclinical testing at Yamanouchi

Aug. 13, 1998

Antidepressant efficacy established with new addition to the Ampakine family

Aug. 13, 1998

NPY Y5 receptor antagonist suppresses feeding and reduces body weight in rodents

Aug. 13, 1998

Sumitomo proves cardioprotective activity of Na+/H+ exchange inhibitor SM-20550

Aug. 12, 1998

Profile of Solvay's dual NEP/ECE inhibitor in clinical testing

Aug. 12, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

NQ-304, a novel platelet antiaggregatory and antithrombotic agent in early development

Aug. 12, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Dual ETA/ETB antagonist provides effective blood pressure control in rats

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...